Aurigene is a specialized, oncology and inflammatory disease focused drug discovery biotech, with deep target and therapeutic area expertise.

Aurigene has pioneered a unique, collaborative business model to work with pharma and biotech partners, in a win-win partnership that combines Aurigene’s deep expertise in oncology and inflammation, with our collaboration partners’ needs for expertise, scalability and high-quality, quick and cost-effective prosecution of targets.

Based in Bangalore, Hyderabad and Kuala Lumpur, Aurigene has a fully integrated Drug Discovery infrastructure from Hit Generation to Pre-clinical development.

Aurigene has collaborated with 6 of the top 10 pharma companies in Discovery collaborations, apart from over 10 other industry leaders around the world, over the last 7 years.

Aurigene is a fast-growing, profitable company that has continuously invested in its people resources, infrastructure and expertise over the years.